Selected research
Industry Research
Biopharmaceutical Quality Analysis Services Industry Research Report 2026
Market perspective
The global Biopharmaceutical Quality Analysis Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biopharmaceutical Quality Analysis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biopharmaceutical Quality Analysis Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biopharmaceutical Quality Analysis Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biopharmaceutical Quality Analysis Services include Labtoo, Analytical Biological Services, Algorithme, Nordic Biosite, LGC, Tentamus Group, AIT Bioscience, Curia Global and Envigo, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biopharmaceutical Quality Analysis Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biopharmaceutical Quality Analysis Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biopharmaceutical Quality Analysis Services Market by Company
Labtoo
Analytical Biological Services
Algorithme
Nordic Biosite
LGC
Tentamus Group
AIT Bioscience
Curia Global
Envigo
Medpace
Merck Millipore Sigma
Eurofins
Concept Bioscience
Biopharmaceutical Quality Analysis Services Segment by Type
Purity Analysis
Structural Analysis
Activity Analysis
Others
Biopharmaceutical Quality Analysis Services Segment by Application
Personal
Commercial
Biopharmaceutical Quality Analysis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Quality Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Quality Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Quality Analysis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biopharmaceutical Quality Analysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Analysis
- Structural Analysis
- Activity Analysis
- Others
Applications
- Personal
- Commercial
Companies covered
- Labtoo
- Analytical Biological Services
- Algorithme
- Nordic Biosite
- LGC
- Tentamus Group
- AIT Bioscience
- Curia Global
- Envigo
- Medpace
- Merck Millipore Sigma
- Eurofins
- Concept Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biopharmaceutical Quality Analysis Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Purity Analysis
- 2.2.3 Structural Analysis
- 2.2.4 Activity Analysis
- 2.2.5 Others
- 2.3 Biopharmaceutical Quality Analysis Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Personal
- 2.3.3 Commercial
- 2.4 Assumptions and Limitations
3 Biopharmaceutical Quality Analysis Services Breakdown Data by Type
- 3.1 Global Biopharmaceutical Quality Analysis Services Historic Market Size by Type (2021-2026)
- 3.2 Global Biopharmaceutical Quality Analysis Services Forecasted Market Size by Type (2027-2032)
4 Biopharmaceutical Quality Analysis Services Breakdown Data by Application
- 4.1 Global Biopharmaceutical Quality Analysis Services Historic Market Size by Application (2021-2026)
- 4.2 Global Biopharmaceutical Quality Analysis Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biopharmaceutical Quality Analysis Services Market Perspective (2021-2032)
- 5.2 Global Biopharmaceutical Quality Analysis Services Growth Trends by Region
- 5.2.1 Global Biopharmaceutical Quality Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biopharmaceutical Quality Analysis Services Historic Market Size by Region (2021-2026)
- 5.2.3 Biopharmaceutical Quality Analysis Services Forecasted Market Size by Region (2027-2032)
- 5.3 Biopharmaceutical Quality Analysis Services Market Dynamics
- 5.3.1 Biopharmaceutical Quality Analysis Services Industry Trends
- 5.3.2 Biopharmaceutical Quality Analysis Services Market Drivers
- 5.3.3 Biopharmaceutical Quality Analysis Services Market Challenges
- 5.3.4 Biopharmaceutical Quality Analysis Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biopharmaceutical Quality Analysis Services Players by Revenue
- 6.1.1 Global Top Biopharmaceutical Quality Analysis Services Players by Revenue (2021-2026)
- 6.1.2 Global Biopharmaceutical Quality Analysis Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Biopharmaceutical Quality Analysis Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biopharmaceutical Quality Analysis Services Head Office and Area Served
- 6.4 Global Biopharmaceutical Quality Analysis Services Players, Product Type & Application
- 6.5 Global Biopharmaceutical Quality Analysis Services Manufacturers Established Date
- 6.6 Global Biopharmaceutical Quality Analysis Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biopharmaceutical Quality Analysis Services Market Size (2021-2032)
- 7.2 North America Biopharmaceutical Quality Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biopharmaceutical Quality Analysis Services Market Size by Country (2021-2026)
- 7.4 North America Biopharmaceutical Quality Analysis Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biopharmaceutical Quality Analysis Services Market Size (2021-2032)
- 8.2 Europe Biopharmaceutical Quality Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biopharmaceutical Quality Analysis Services Market Size by Country (2021-2026)
- 8.4 Europe Biopharmaceutical Quality Analysis Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biopharmaceutical Quality Analysis Services Market Size (2021-2032)
- 9.2 Asia-Pacific Biopharmaceutical Quality Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biopharmaceutical Quality Analysis Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biopharmaceutical Quality Analysis Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biopharmaceutical Quality Analysis Services Market Size (2021-2032)
- 10.2 South America Biopharmaceutical Quality Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biopharmaceutical Quality Analysis Services Market Size by Country (2021-2026)
- 10.4 South America Biopharmaceutical Quality Analysis Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceutical Quality Analysis Services Market Size (2021-2032)
- 11.2 Middle East & Africa Biopharmaceutical Quality Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biopharmaceutical Quality Analysis Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biopharmaceutical Quality Analysis Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Labtoo
- 12.1.1 Labtoo Company Information
- 12.1.2 Labtoo Business Overview
- 12.1.3 Labtoo Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.1.4 Labtoo Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.1.5 Labtoo Recent Developments
- 12.2 Analytical Biological Services
- 12.2.1 Analytical Biological Services Company Information
- 12.2.2 Analytical Biological Services Business Overview
- 12.2.3 Analytical Biological Services Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.2.4 Analytical Biological Services Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.2.5 Analytical Biological Services Recent Developments
- 12.3 Algorithme
- 12.3.1 Algorithme Company Information
- 12.3.2 Algorithme Business Overview
- 12.3.3 Algorithme Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.3.4 Algorithme Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.3.5 Algorithme Recent Developments
- 12.4 Nordic Biosite
- 12.4.1 Nordic Biosite Company Information
- 12.4.2 Nordic Biosite Business Overview
- 12.4.3 Nordic Biosite Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.4.4 Nordic Biosite Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.4.5 Nordic Biosite Recent Developments
- 12.5 LGC
- 12.5.1 LGC Company Information
- 12.5.2 LGC Business Overview
- 12.5.3 LGC Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.5.4 LGC Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.5.5 LGC Recent Developments
- 12.6 Tentamus Group
- 12.6.1 Tentamus Group Company Information
- 12.6.2 Tentamus Group Business Overview
- 12.6.3 Tentamus Group Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.6.4 Tentamus Group Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.6.5 Tentamus Group Recent Developments
- 12.7 AIT Bioscience
- 12.7.1 AIT Bioscience Company Information
- 12.7.2 AIT Bioscience Business Overview
- 12.7.3 AIT Bioscience Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.7.4 AIT Bioscience Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.7.5 AIT Bioscience Recent Developments
- 12.8 Curia Global
- 12.8.1 Curia Global Company Information
- 12.8.2 Curia Global Business Overview
- 12.8.3 Curia Global Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.8.4 Curia Global Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.8.5 Curia Global Recent Developments
- 12.9 Envigo
- 12.9.1 Envigo Company Information
- 12.9.2 Envigo Business Overview
- 12.9.3 Envigo Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.9.4 Envigo Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.9.5 Envigo Recent Developments
- 12.10 Medpace
- 12.10.1 Medpace Company Information
- 12.10.2 Medpace Business Overview
- 12.10.3 Medpace Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.10.4 Medpace Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.10.5 Medpace Recent Developments
- 12.11 Merck Millipore Sigma
- 12.11.1 Merck Millipore Sigma Company Information
- 12.11.2 Merck Millipore Sigma Business Overview
- 12.11.3 Merck Millipore Sigma Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.11.4 Merck Millipore Sigma Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.11.5 Merck Millipore Sigma Recent Developments
- 12.12 Eurofins
- 12.12.1 Eurofins Company Information
- 12.12.2 Eurofins Business Overview
- 12.12.3 Eurofins Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.12.4 Eurofins Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.12.5 Eurofins Recent Developments
- 12.13 Concept Bioscience
- 12.13.1 Concept Bioscience Company Information
- 12.13.2 Concept Bioscience Business Overview
- 12.13.3 Concept Bioscience Revenue in Biopharmaceutical Quality Analysis Services Business (2021-2026)
- 12.13.4 Concept Bioscience Biopharmaceutical Quality Analysis Services Product Portfolio
- 12.13.5 Concept Bioscience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst